Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
2.11M
Cost of Revenue
n/a
Gross Profit
2.11M
Operating Income
-35.42M
Interest Income
815.32K
Pretax Income
-35.55M
Net Income
-35.4M
Selling & General & Admin
16.83M
Research & Development
18.82M
Other Expenses
1.88M
Operating Expenses
37.53M
Interest Expense
127.74K
Selling & Marketing Expenses
n/a
Cost & Expenses
37.53M
Income Tax Expense
-145.97K
Shares Outstanding (Basic)
25.14M
Shares Outstanding (Diluted)
25.14M
EPS (Basic)
-1.41
EPS (Diluted)
-1.41
EBITDA
-35.55M
EBIT
-35.42M
Depreciation & Amortization
-127.74K